Detalhe da pesquisa
1.
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Lancet
; 401(10378): 747-761, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746171
2.
Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
Acta Derm Venereol
; 103: adv14153, 2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800349
3.
Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre study.
Clin Exp Dermatol
; 48(5): 528-530, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702808
4.
Switching biologics in children with psoriasis: Results from the BiPe cohort.
Pediatr Dermatol
; 39(1): 35-41, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34888920
5.
Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa.
Dermatology
; 236(1): 25-30, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630144
6.
Impact of the COVID-19 Pandemic on Chronic Inflammatory Dermatoses: Mixed Messages Regarding the Dermatologist's Point of View and the Patient's Concerns.
Acta Derm Venereol
; 100(15): adv00248, 2020 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735023
7.
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis.
Acta Derm Venereol
; 100(18): adv00316, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33111960
8.
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
N Engl J Med
; 375(5): 422-34, 2016 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27518661
9.
Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
Exp Dermatol
; 28(5): 593-600, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30903721
10.
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
J Am Acad Dermatol
; 81(1): 143-151, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30825533
11.
A systematic review of dimensions evaluating patient experience in chronic illness.
Health Qual Life Outcomes
; 17(1): 19, 2019 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665417
12.
[New therapeutic strategies in psoriasis]. / Nouvelles stratégies thérapeutiques dans le psoriasis.
Rev Prat
; 68(9): 972-977, 2018 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-30869351
13.
Socioeconomic Inequalities and Severity of Plaque Psoriasis at a First Consultation in Dermatology Centers.
Acta Derm Venereol
; 97(5): 632-638, 2017 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28127620
14.
Efficacy and Safety of Methotrexate Combined with Low- to Moderate-Dose Corticosteroids for Severe Alopecia Areata.
Dermatology
; 232(2): 242-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26735937
15.
[Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice]. / Ustekinumab dans le rhumatisme psoriasique après échec des anti-TNFα en pratique courante.
Therapie
; 71(3): 281-6, 2016 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-27235651
16.
Hidradenitis suppurativa management using tumor necrosis factor inhibitors in patients younger than 18 years: A series of 12 cases.
J Am Acad Dermatol
; 83(1): 199-201, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32151626
17.
Factors associated with successful switching between biologic therapies for the treatment of psoriasis in daily dermatological real-life practice: The Resoswitch study.
Dermatol Ther
; 32(2): e12789, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488520
18.
Assessment of bullous pemphigoid disease area index during treatment: a prospective study of 30 patients.
Dermatology
; 229(2): 116-22, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25011586
19.
Combining Omalizumab with Another Biotherapy.
Acta Derm Venereol
; 99(4): 448-449, 2019 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723874
20.
Patient Burden is Associated with Alterations in Quality of Life in Adult Patients with Atopic Dermatitis: Results from the ECLA Study.
Acta Derm Venereol
; 98(7): 713-714, 2018 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29648674